CureApp, Inc.

CureApp is a Japanese company developing and marketing prescription-based digital therapeutics (DTx) applications, primarily focused on treating lifestyle-related diseases like hypertension, nicotine dependence, and non-alcoholic steatohepatitis (NASH). Their goal is to "re-evolve therapeutics with software" by providing patients with personalized and accessible treatment plans through their smartphone apps, which are designed to support behavioral changes and improve adherence to medical advice. CureApp collaborates with medical institutions and researchers to develop evidence-based solutions, ensuring the safety and efficacy of their products.

Beyond their core DTx app development, CureApp offers a range of services including corporate health programs, such as "ascure," which combines DTx apps, online coaching, and medication delivery to promote smoking cessation and healthier lifestyles within organizations. They also have a US subsidiary, CureApp North America, Inc., which is dedicated to expanding their reach globally. CureApp's commitment to innovation and partnership with healthcare professionals positions them as a leader in the field of digital therapeutics, aiming to improve patient outcomes and contribute to a healthier future.

CureApp offers flexible work arrangements including a combination of flextime, remote work, and a focus on work-life balance. The company values its employees' well-being and provides support for employees to manage their work and personal life, including childcare and nursing care.

CureApp offers a comprehensive benefits package designed to support employee well-being and promote a healthy work-life balance. This includes a flexible work schedule with options for remote work, parental leave policies, and a comprehensive health insurance plan. They also provide opportunities for professional development and encourage employees to pursue their passions through company-sponsored initiatives.

CureApp's mission is to revolutionize "therapeutics" with software, striving to create a future where everyone can access high-quality medical treatment without worry. They achieve this by developing evidence-based, clinically-validated "Digital Therapeutics" (DTx) apps that address conditions where conventional treatments are insufficient. CureApp believes that their technology, which promotes behavior modification, can address critical healthcare challenges such as rising medical costs and disparities in access to care.

CureApp promotes a culture of innovation, collaboration, and responsibility. They encourage their employees to challenge the status quo, think creatively, and work together to achieve their shared goal of improving healthcare through technology. They value individual growth and development, fostering an environment where employees can learn from each other and take ownership of their work. CureApp is also committed to social responsibility, reflected in their dedication to developing and deploying digital therapeutics that address healthcare disparities and improve access to quality care.

CureApp recognizes the importance of diversity, equity, and inclusion (DEI) for a thriving workplace and a positive impact on the company's products and services. They have established a DEI policy that focuses on creating a welcoming environment where differences in backgrounds and values are celebrated and employees can feel comfortable being themselves. They aim for fairness in all aspects of employment, including opportunities, evaluations, and compensation, regardless of individual characteristics. CureApp also strives to ensure that their products and services are accessible and inclusive, considering the needs of diverse users.